dc.contributor.author | Taremi, M. | |
dc.contributor.author | Alizadeh, A.H. Mohammad | |
dc.contributor.author | Ardalan, A. | |
dc.contributor.author | Ansari, S. | |
dc.contributor.author | Zali, M.R. | |
dc.date.accessioned | 2014-06-17T08:17:43Z | |
dc.date.available | 2014-06-17T08:17:43Z | |
dc.date.issued | 2008 | EN |
dc.identifier.issn | 1020-3397 | EN |
dc.identifier.other | http://applications.emro.who.int/emhj/1401/14_1_2008_157_162.pdf | EN |
dc.identifier.uri | https://iris.who.int/handle/10665/117420 | |
dc.description | 157-162 | EN |
dc.description.abstract | A 2-month community-based survey in February/March of 2003 was carried out to study the seroprevalence of hepatitis E virus [HEV] infection in Nahavand, Islamic Republic of Iran. From each of 6 urban regions of Nahavand, 304 inhabitants >/= 6 years were recruited through systematic random sampling [total 1824]. Participants were tested for anti-HEV IgG using ELISA. The overall seroprevalence of HEV was 9.3% [95% CI: 8.2%-10.9%]. Based on multivariate adjustment, only sex [OR = 1.61, 95% CI: 1.13-2.28] and age [OR = 1.03, 95% CI: 1.01-1.04] emerged as significant risk factors. This intermediate prevalence urges further investigations on HEV infection in the Islamic Republic of Iran | EN |
dc.language.iso | en | EN |
dc.subject | Hepatitis E | EN |
dc.subject | Hepatitis E virus | EN |
dc.subject | Seroepidemiologic Studies | EN |
dc.subject | Enzyme-Linked Immunosorbent Assay | EN |
dc.subject | Cross-Sectional Studies | EN |
dc.subject.mesh | Hepatitis E | EN |
dc.title | Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study | EN |
dc.relation.ispartofjournal | EMHJ - Eastern Mediterranean Health Journal, 14 (1), 157-162, 2008 | |